Allergan Inc Q1 2018 Big Money Sentiment Better Than Expected, now at 0.5

June 27, 2018 - By Nell Hawkins

Allergan plc (NYSE:AGN) Corporate Logo

“Big money” Positions

In Q1 2018 Allergan Inc (NYSE:AGN) big money sentiment decreased to 0.5, according to Securities and Exchange Commission filings. That’s down -0.75, from 2017Q4’s 1.25. 2 active investment managers increased or started new positions, while 4 cut down and sold their positions in Allergan Inc so the sentiment dropped. Funds own 77,429 shares, up from 44,210 shares in 2017Q4. Funds holding Allergan Inc in top 10 was flat from 0 to 0 for the same number . 1 Investors Sold All; 3 Reduced Holdings; 2 increased holdings while 0 active investment managers bought holdings.

Significant Allergan Inc Investors

As of Q1 2018 Grassi Investment Management has 1.16% invested in Allergan Inc. Allergan Inc’s shareholder Callahan Advisors Llc owns 15,273 shares as of Q1 2018. Mitchell Mcleod Pugh & Williams Inc reported 3,965 shares. The Massachusetts-based fund Cubic Asset Management Llc have invested about 0.1% of the fund’s stock portfolio in Allergan Inc. The California-based fund Gemmer Asset Management Llc holds 101 shares or 0.01% of their stock exposure.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide.The firm is worth $57.40 billion. It operates through US Specialized Therapeutics, US General Medicine, and International divisions.Currently it has negative earnings. The firm offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, womenÂ’s health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as AlzheimerÂ’s disease.

The stock decreased 0.36% or $0.62 during the last trading session, touching $169.29.Allergan plc has volume of 55,184 shares. Since June 27, 2017 AGN has declined 31.36% and is downtrending. AGN underperformed the S&P 500 by 43.93%.

On August, 2 Allergan plc (NYSE:AGN)’s earnings report is awaited by WallStreet, according to Faxor. The EPS diference is $0.11 or 2.74 % up from last years number. Previous year: $4.02; Analysts forcast: $4.13. If AGN’s EPS is $4.13 the profit will reach $1.40 billion for 10.25 P/E. Wall Street sees 10.43 % EPS growth as of August, 2.

Frontier Investment Management holds 0% of its capital in Allergan plc (NYSE:AGN) for 13,592 shs. Cubic Asset Ltd Liability has 2,130 shs for 0.1% of their capital. Callahan Advsr Ltd Liability Corp has invested 0.53% in Allergan plc (NYSE:AGN). Gemmer Asset Mgmt Limited Liability Com reported 101 shs or 0.01% of all its holdings. American Rech And Com owns 33 shs. California-based Grassi Inv has invested 1.16% in Allergan plc (NYSE:AGN). Moreover, Mitchell Mcleod Pugh Williams Inc has 0.48% invested in Allergan plc (NYSE:AGN) for 3,965 shs.

Allergan plc (NYSE:AGN) Ratings Coverage

A total of 16 analysts rate Allergan (NYSE:AGN) as follows: 11 “Buy”, 5 “Hold” and 0 “Sell”. Тherefore 69% are bullish. The firm has $25500 highest and $15000 lowest target. The avg target $207.73 is 22.71% above the last ($169.29) price. (NYSE:AGN) has 27 ratings reports on 27 Jun 2018 according to StockzIntelligence. The stock rating was upgraded by Barclays Capital to “Overweight” on Monday, January 29. On Thursday, January 4 the firm has “Buy” rating given by RBC Capital Markets. On Monday, May 7 the firm has “Hold” rating given by Cantor Fitzgerald. On Wednesday, January 3 the stock has “Buy” rating by Leerink Swann. In Monday, April 30 report Mizuho maintained the stock with “Hold” rating. In Wednesday, May 30 report Mizuho maintained it with “Hold” rating and $15000 target. On Tuesday, February 6 the stock of Allergan plc (NYSE:AGN) has “Hold” rating given by Piper Jaffray. On Thursday, May 3 Credit Suisse maintained Allergan plc (NYSE:AGN) with “Outperform” rating. On Tuesday, May 1 the firm has “Outperform” rating by Wells Fargo given. On Wednesday, January 17 the stock of Allergan plc (NYSE:AGN) has “Hold” rating given by Susquehanna.

For more Allergan plc (NYSE:AGN) news released recently go to: Benzinga.com, Prnewswire.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Bernstein: What Activism Means For Allergan Shareholders” released on June 08, 2018, “Advancing Neurostimulation Therapies for Optical Deficiencies Impacting Healthcare Industry in a Billion Dollar Way” on June 27, 2018, “The ‘Joe Papa’ Effect Is Arriving At Valeant” with a publish date: June 11, 2018, “Allergan: Unwelcome Guests?” and the last “Allergan Needs Earnings To Be Sustained” with publication date: June 05, 2018.

Allergan plc (NYSE:AGN) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: